Comparison
While Ipamorelin is investigated for producing moderate, physiologic-like GH pulses useful for studying anabolic, body-composition, and recovery effects with a relatively clean endocrine side-effect profile compared with earlier GHRPs16, Tirzepatide is approved for type 2 diabetes and obesity, producing larger HbA1c and body-weight reductions than semaglutide in head-to-head trials24.
While Ipamorelin works as a third-generation pentapeptide growth hormone secretagogue that selectively agonizes the ghrelin (GHSR-1a) receptor to trigger controlled, GH-specific pituitary release with minimal effects on cortisol or prolactin16269596, Tirzepatide is a 39-amino-acid synthetic peptide primarily based on GIP sequence with C20 fatty diacid conjugation that acts as a dual agonist at GIP and GLP-1 receptors, enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite24.
Ipamorelin is 5 amino acids long, whereas Tirzepatide is longer as it has a length of 39 amino acids. Ipamorelin is made up of a sequence of Aib, Histidine, D-2-Nal, Phenylalanine, Lysine. Tirzepatide is made up of a sequence of sequence data not available in the current dataset.
Ipamorelin
GHSR
Tirzepatide
Not assigned in the current dataset.